Waystar to acquire Iodine Software from Advent for $1.25bn.

Waystar, a provider of healthcare payment software, agreed to acquire Iodine Software, an AI-powered clinical intelligence, from Advent, a private equity firm, for $1.25bn. "Our mission is to simplify healthcare payments by eradicating unnecessary denied claims, automating manual work, and increasing transparency for providers and patients. We are committed to transforming healthcare through harnessing the power of AI to tackle the most critical challenges in healthcare payments. Welcoming Iodine's talented team and clinical intelligence platform to Waystar is a terrific next step in achieving our mission," Matt Hawkins, Waystar CEO.